Neurona Therapeutics
South San Francisco, California, United StatesFounded 200896+ employeesPrivate
$440.1M raisedGrowth· last: grant (Jun 2025)· 13 rounds
Backed by(24 investors)
California Institute for Regenerative Medicine · LeadThe Column Group · LeadCormorant Asset Management · LeadNational Institutes of Health · LeadSouth Carolina Research Authority · LeadUCB Ventures · LeadViking Global Investors · Lead+9 more
1 layoff event · Last: Feb 2023
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.
